Overview

Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature Babies

Status:
Completed
Trial end date:
2015-07-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of inhaled nitric oxide to reduce the risk of chronic lung disease in pre-term infants with respiratory distress, and to assess the long-term effects of the therapy on the development of these children over 7 years of clinical follow-up.
Phase:
Phase 3
Details
Lead Sponsor:
Mallinckrodt
Treatments:
Nitric Oxide